Current pathology practices in and barriers to MDS diagnosis.

[1]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[2]  L. Arenillas,et al.  Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes , 2013, Haematologica.

[3]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[4]  Z. Estrov,et al.  Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. , 2011, Blood.

[5]  M. Fey,et al.  Clinical Practice Guidelines Acute Myeloblastic Leukaemias and Myelodysplastic Syndromes in Adult Patients: Esmo Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up on Behalf of the Esmo Guidelines Working Group* Risk Assessment and Prognostic Factors , 2022 .

[6]  J. Bennett,et al.  Myelodysplastic syndromes classification and risk stratification. , 2010, Hematology/oncology clinics of North America.

[7]  J. Issa,et al.  The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities , 2009, Cancer.

[8]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[9]  B. Bain,et al.  Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts , 2008, Haematologica.

[10]  A. Porwit,et al.  ICSH guidelines for the standardization of bone marrow specimens and reports , 2008, International journal of laboratory hematology.

[11]  M. Cazzola,et al.  Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Jeff Luck,et al.  Measuring the Quality of Physician Practice by Using Clinical Vignettes: A Prospective Validation Study , 2004, Annals of Internal Medicine.

[13]  J. Issa,et al.  Myelodysplastic syndromes. , 2004, Hematology. American Society of Hematology. Education Program.

[14]  N. Harris,et al.  The World Health Organization (WHO) classification of the myeloid neoplasms. , 2002, Blood.

[15]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[16]  D. Galton.  The myelodysplastic syndromes. , 1987, Clinical and laboratory haematology.

[17]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.